131 related articles for article (PubMed ID: 14573810)
1. Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4.
Yap IS; Giddings G; Pocock E; Chantler JK
J Gen Virol; 2003 Nov; 84(Pt 11):3051-3068. PubMed ID: 14573810
[TBL] [Abstract][Full Text] [Related]
2. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
3. Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release.
Frisk G; Diderholm H
Int J Exp Diabetes Res; 2000; 1(3):165-75. PubMed ID: 11467407
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of the pancreas after oral infection of genetically diverse mice with coxsackievirus B4-E2.
Precechtelova J; Borsanyiova M; Stipalova D; Sarmirova S; Gomolcak P; Berakova K; Bopegamage S
Arch Virol; 2015 Jan; 160(1):103-15. PubMed ID: 25293347
[TBL] [Abstract][Full Text] [Related]
5. Effect of coxsackievirus B4 infection in mice on expression of 64,000-Mr autoantigen and glucose sensitivity of islets before development of hyperglycemia.
Gerling I; Nejman C; Chatterjee NK
Diabetes; 1988 Oct; 37(10):1419-25. PubMed ID: 2843410
[TBL] [Abstract][Full Text] [Related]
6. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
7. Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance.
Hindersson M; Orn A; Harris RA; Frisk G
Arch Virol; 2004 Oct; 149(10):1985-2000. PubMed ID: 15669109
[TBL] [Abstract][Full Text] [Related]
8. Lack of 64,000-M(r) islet autoantigen overexpression and antibody development following coxsackievirus B4 infection in diabetes-resistant mice.
Gerling I; Chatterjee NK
Autoimmunity; 1993; 14(3):197-203. PubMed ID: 8392390
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of virus-induced diabetes in mice.
See DM; Tilles JG
J Infect Dis; 1995 May; 171(5):1131-8. PubMed ID: 7751687
[TBL] [Abstract][Full Text] [Related]
10. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.
Chehadeh W; Kerr-Conte J; Pattou F; Alm G; Lefebvre J; Wattré P; Hober D
J Virol; 2000 Nov; 74(21):10153-64. PubMed ID: 11024144
[TBL] [Abstract][Full Text] [Related]
11. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.
Yin H; Berg AK; Westman J; Hellerström C; Frisk G
J Med Virol; 2002 Dec; 68(4):544-57. PubMed ID: 12376963
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection.
Hou J; Sheikh S; Martin DL; Chatterjee NK
J Autoimmun; 1993 Oct; 6(5):529-42. PubMed ID: 8240659
[TBL] [Abstract][Full Text] [Related]
13. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells.
Ylipaasto P; Klingel K; Lindberg AM; Otonkoski T; Kandolf R; Hovi T; Roivainen M
Diabetologia; 2004 Feb; 47(2):225-39. PubMed ID: 14727023
[TBL] [Abstract][Full Text] [Related]
14. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
Stone VM; Hankaniemi MM; Svedin E; Sioofy-Khojine A; Oikarinen S; Hyöty H; Laitinen OH; Hytönen VP; Flodström-Tullberg M
Diabetologia; 2018 Feb; 61(2):476-481. PubMed ID: 29151123
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus B4-induced development of antibodies to 64,000-Mr islet autoantigen and hyperglycemia in mice.
Gerling I; Chatterjee NK; Nejman C
Autoimmunity; 1991; 10(1):49-56. PubMed ID: 1660313
[TBL] [Abstract][Full Text] [Related]
16. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction.
Ylipaasto P; Smura T; Gopalacharyulu P; Paananen A; Seppänen-Laakso T; Kaijalainen S; Ahlfors H; Korsgren O; Lakey JR; Lahesmaa R; Piemonti L; Oresic M; Galama J; Roivainen M
Diabetologia; 2012 Dec; 55(12):3273-83. PubMed ID: 22983635
[TBL] [Abstract][Full Text] [Related]
17. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo.
Al-Hello H; Davydova B; Smura T; Kaialainen S; Ylipaasto P; Saario E; Hovi T; Rieder E; Roivainen M
J Med Virol; 2005 Apr; 75(4):566-74. PubMed ID: 15714484
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
